CLINICAL FEATURES AND RISK FACTORS FOR CLEVUDINE RESISTANCE IN TREATMENT-NAiVE CHRONIC HEPATITIS B PATIENTS

被引：0
|
作者：
Yim, Hyung Joon [1 ]
Kim, Jeong Han [1 ]
Choi, You-me [1 ]
Jung, Young Kul [1 ]
Jung, Eun Suk [1 ]
Kim, Ji Hoon [1 ]
Seo, Yeon Seok [1 ]
Yeon, Jong Eun [1 ]
Byun, Kwan Soo [1 ]
Um, Soon Ho [1 ]
Ryu, Ho Sang [1 ]
机构：
[1] Korea Univ, Coll Med, Seoul 136705, South Korea
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
465
引用
收藏
页码：525A / 525A
页数：1
相关论文
共 50 条
  • [41] PARTIAL VIROLOGICAL RESPONSE TO ENTECAVIR IN TREATMENT-NAiVE CHRONIC HEPATITIS B
    Kim, Seung Up
    Chon, Young Eun
    Lee, Chun Kyon
    Heo, Jeong
    Kim, Ja Kyung
    Yoon, Ki Tae
    Cho, Mong
    Lee, Kwan Sik
    Kim, Dong Hwan
    Choi, Eun Hee
    Park, Jun Yong
    Kim, Do Young
    Chon, Chae Yoon
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    HEPATOLOGY, 2010, 52 (04) : 501A - 502A
  • [42] Systematic review: combination therapies for treatment-naive chronic hepatitis B
    Kumar, M.
    Sarin, S. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) : 1187 - 1209
  • [43] A personalized approach to optimize hepatitis B treatment in treatment-naive patients
    Marcellin, Patrick
    Liang, Jake
    ANTIVIRAL THERAPY, 2010, 15 : 53 - 59
  • [44] Tenofovir is Superior to Entecavir in Patients with Treatment-naive Hepatitis B e-Antigen-Positive Chronic Hepatitis B
    Behera, Manas K.
    Pati, Girish K.
    Narayan, Jimmy
    Mishra, Debakanta
    Meher, Lalit K.
    Singh, Ayaskant
    Uthansingh, Kanishka
    Sahu, Manoj K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (01) : 37 - 44
  • [45] Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients
    Pastor, Rebecca
    Habersetzer, Francois
    Fafi-Kremer, Samira
    Doffoel, Michel
    Baumert, Thomas F.
    Gut, Jean-Pierre
    Stoll-Keller, Francoise
    Schvoerer, Evelyne
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (06) : 753 - 755
  • [46] Clevudine-induced HBV DNA suppression at 24 weeks in treatment-naive patients with chronic hepatitis B is a good predictive factor for virological response at 48 weeks
    Lee, H. W.
    Kim, H. J.
    Kim, K. A.
    Lee, J. S.
    Baek, E. K.
    Kim, K. S.
    Cha, B. K.
    Oh, H. C.
    Choi, C. H.
    Kim, J. W.
    Do, J. H.
    Kim, J. G.
    Chang, S. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A169 - A169
  • [47] Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients
    Jardi, R.
    Rodriguez-Frias, F.
    Schaper, M.
    Ruiz, G.
    Elefsiniotis, I.
    Esteban, R.
    Buti, M.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (12) : 835 - 840
  • [48] Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naive chronic hepatitis B patients
    Li, Min-Ran
    Lu, Jian-Hua
    Ye, Li-Hong
    Sun, Xing-Li
    Zheng, Yan-Hua
    Liu, Zhi-Quan
    Zhang, Hai-Cong
    Liu, Yun-Yan
    Lv, Ying
    Huang, Yan
    Dai, Er-Hei
    MEDICINE, 2016, 95 (34)
  • [49] Hepatitis B virus mutations potentially conferring adefovir/ tenofovir resistance in treatment-naive patients
    Rebecca Pastor
    Franois Habersetzer
    Samira Fafi-Kremer
    Michel Doffoёl
    Thomas F Baumert
    Jean-Pierre Gut
    Franoise Stoll-Keller
    Evelyne Schvoerer
    World Journal of Gastroenterology, 2009, 15 (06) : 753 - 755
  • [50] Cirrhosis related to Chronic Hepatitis C Virus Infection and Factors Associated in Treatment-naive Hepatitis C Patients
    Darnindro, Nikko
    Mulyana, Edi
    Harahap, Arnold
    Manurung, Annela
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 136 - 136
12345